I sure agree with you GAC.

While I feel these presentations are important to build brand credibility they do not address investment markets.

RVX has no analyst coverage. It is listed on the TSX thus a limited pool of high risk investors and it does not have the breadth of a NASDAQ exposure and credibiltiy. And the company's great achievements are not promoted.

I still believe we are on the cusp of a huge scientific and medical breakthrough but the story is not being told. I remain confident because of the scientific posters and the continuing good scientific news that we witnessed this week.

It's a pity to see this gem of a stock just sit there unsupported. We all know the problems so we'll have to wait for a deal.

GLTA

Toinv